| Turkey | Vienna | Spain | |
| Targeted therapy | from $3,000 | ≈ $4,500 | from $5,000 |
| Oncothermia | ≈ $2,400 | ≈ $2,900 | ≈ $2,200 |
| Lutetium-177 therapy | from $6,500 | ≈ $12,000 | ≈ $7,500 |
| Actinium-225 Therapy | ≈ $9,000 | ≈ $12,500 | ≈ $28,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
Day 1: Arrival
Day 2: Pre-Operation Stage
Day 3: Targeted Therapy
Day 4: Post-Operation Stage
Week 1-2: Rehabilitation
Please note that each patient"s case is individual and can vary.
22 years specializing in targeted therapies – Prof. Köstler leads pioneering work in personalized cancer medicine at Wiener Privatklinik.
Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.
He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.
Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.
Dr. Christoph Zielinski is a prominent oncologist and Chairman of the Vienna Cancer Center. He serves as Medical Director of the International Oncology Center at Wiener Privatklinik. Dr. Zielinski specializes in immunotherapy and hematology. He has published over 600 scientific papers on individualized cancer treatment. Dr. Zielinski works at Wiener Privatklinik, a hospital ranked among the world's best by Newsweek.
Written by Anna Shchur